[
  {
    "ts": null,
    "headline": "10 Charts That Show The Unprecedented Scale Of The Magnificent 7 Bubble",
    "summary": "The Magnificent Seven stocks represent 33% of the entire S&P 500's market cap. Click here to read more about Mag 7 stocks through charts.",
    "url": "https://finnhub.io/api/news?id=b6ae67f60f8f53d62811557bd2910b9029210d111eebf853cfa1284539f6f70e",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733781324,
      "headline": "10 Charts That Show The Unprecedented Scale Of The Magnificent 7 Bubble",
      "id": 131895596,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/487259374/image_487259374.jpg?io=getty-c-w1536",
      "related": "PFE",
      "source": "SeekingAlpha",
      "summary": "The Magnificent Seven stocks represent 33% of the entire S&P 500's market cap. Click here to read more about Mag 7 stocks through charts.",
      "url": "https://finnhub.io/api/news?id=b6ae67f60f8f53d62811557bd2910b9029210d111eebf853cfa1284539f6f70e"
    }
  },
  {
    "ts": null,
    "headline": "Novartis Announces Positive Results From Late-Stage Study on Fabhalta",
    "summary": "NVS' Fabhalta improves the average hemoglobin level compared to baseline in adult patients with PNH who switched from anti-C5 therapies.",
    "url": "https://finnhub.io/api/news?id=91f457f1eade0d4ee79f8ccd67d6505b17ce0501b5c672c02241d01d7237ddf8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733768340,
      "headline": "Novartis Announces Positive Results From Late-Stage Study on Fabhalta",
      "id": 131872917,
      "image": "https://media.zenfs.com/en/zacks.com/f166d65586ad9d3236a947b8d942f4c9",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "NVS' Fabhalta improves the average hemoglobin level compared to baseline in adult patients with PNH who switched from anti-C5 therapies.",
      "url": "https://finnhub.io/api/news?id=91f457f1eade0d4ee79f8ccd67d6505b17ce0501b5c672c02241d01d7237ddf8"
    }
  },
  {
    "ts": null,
    "headline": "PFE or NVO: Which Is the Better Value Stock Right Now?",
    "summary": "PFE vs. NVO: Which Stock Is the Better Value Option?",
    "url": "https://finnhub.io/api/news?id=e4bf7ff4fae0bb388d8e3d5ce8bc6fd2d87269f759e6c608c0077e5d7b80d6c8",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733762411,
      "headline": "PFE or NVO: Which Is the Better Value Stock Right Now?",
      "id": 131872003,
      "image": "https://media.zenfs.com/en/zacks.com/078b2d95159d12a337f09f2519ff10ba",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "PFE vs. NVO: Which Stock Is the Better Value Option?",
      "url": "https://finnhub.io/api/news?id=e4bf7ff4fae0bb388d8e3d5ce8bc6fd2d87269f759e6c608c0077e5d7b80d6c8"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
    "url": "https://finnhub.io/api/news?id=a6a08acb85b9bacd1c9a798fe1f9c29c3ac977b0ab282786c1c350618b986603",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733762340,
      "headline": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "id": 131935414,
      "image": "",
      "related": "PFE",
      "source": "MarketWatch",
      "summary": "Pfizer Inc. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=a6a08acb85b9bacd1c9a798fe1f9c29c3ac977b0ab282786c1c350618b986603"
    }
  },
  {
    "ts": null,
    "headline": "FDA Accepts GSK's Filing for Expanded Use of Nucala in COPD",
    "summary": "The FDA accepts GSK's regulatory filing seeking the expanded use of Nucala in COPD treatment for review.",
    "url": "https://finnhub.io/api/news?id=ee4d30fc3781f219b8718a48cee7512160dd91a3988a3b07653e99505188f6de",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733761560,
      "headline": "FDA Accepts GSK's Filing for Expanded Use of Nucala in COPD",
      "id": 131872004,
      "image": "https://media.zenfs.com/en/zacks.com/b5aeac1c53d022d48463312844fb1baf",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "The FDA accepts GSK's regulatory filing seeking the expanded use of Nucala in COPD treatment for review.",
      "url": "https://finnhub.io/api/news?id=ee4d30fc3781f219b8718a48cee7512160dd91a3988a3b07653e99505188f6de"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It",
    "summary": "Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",
    "url": "https://finnhub.io/api/news?id=66a740c9981789f506d77c954075849e2d6211cbf42227f876df17ee990d6e79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733752816,
      "headline": "Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It",
      "id": 131872005,
      "image": "https://media.zenfs.com/en/zacks.com/a41b81fe729c761f3f94f42ff348f70c",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.",
      "url": "https://finnhub.io/api/news?id=66a740c9981789f506d77c954075849e2d6211cbf42227f876df17ee990d6e79"
    }
  },
  {
    "ts": null,
    "headline": "AZN's Bladder Cancer sBLA for Imfinzi Gets FDA's Priority Tag",
    "summary": "FDA grants priority review to AZN's sBLA seeking expanded use of Imfinzi for muscle-invasive bladder cancer.",
    "url": "https://finnhub.io/api/news?id=dbd14b2940dd9ab8444bdc33114d1af99f4dc610f24a319407ccc532f4214772",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733749140,
      "headline": "AZN's Bladder Cancer sBLA for Imfinzi Gets FDA's Priority Tag",
      "id": 131872006,
      "image": "https://media.zenfs.com/en/zacks.com/9883d206905e7516b2353476e213e60c",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "FDA grants priority review to AZN's sBLA seeking expanded use of Imfinzi for muscle-invasive bladder cancer.",
      "url": "https://finnhub.io/api/news?id=dbd14b2940dd9ab8444bdc33114d1af99f4dc610f24a319407ccc532f4214772"
    }
  },
  {
    "ts": null,
    "headline": "Apple Tops the List of Best-Managed Companies of 2024",
    "summary": "Tech companies hold six of the top 10 spots, while Mastercard jumped to fifth place from 24th last year.",
    "url": "https://finnhub.io/api/news?id=d13cca814be7a6fe4ddcc7139ff6790f37d3900f98cf04b25ea44b1a3c44b23e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1733710440,
      "headline": "Apple Tops the List of Best-Managed Companies of 2024",
      "id": 131864915,
      "image": "https://media.zenfs.com/en/wsj.com/7b2c285183be07ca3c4e8242b25a59a8",
      "related": "PFE",
      "source": "Yahoo",
      "summary": "Tech companies hold six of the top 10 spots, while Mastercard jumped to fifth place from 24th last year.",
      "url": "https://finnhub.io/api/news?id=d13cca814be7a6fe4ddcc7139ff6790f37d3900f98cf04b25ea44b1a3c44b23e"
    }
  }
]